Loading...
Loading...
Loading...
Loading...
Delta Opioid Receptor 358-372 Blocking Peptide
| Size | 20 µg |
| Estimated Lead Time | 1-2 weeks |
| Expressed Region | TACTPSDGPGGGAAA |
| Molecular Weight (kDa) | 1232 |
| Format | Lyophilized |
| Recommended Applications | Used for absorption control of antiserum binding. Antibody should be pre-incubated with peptide prior to incubation with tissue/sample. We suggest perincubation for 1 hour at room temperature. A 10^-6 or 10^-5 molar (M) peptide concentration is suggested, Used for absorption control of antiserum binding. Antibody should be pre-incubated with peptide prior to incubation with tissue/sample. We suggest perincubation for 1 hour at room temperature. A 10^-6 or 10^-5 molar (M) peptide concentration is suggested to block antigen/antibody binding. However, optimal working concentration should be determined by the investigator using a range of peptide dilutions to eliminate or reduce immunoreactivity. |
| Research Area | Neuroscience, Addiction and Drug Dependency |
| Shipping Type | Ambient temperature |
| Storage | -20°C |
Your cart is empty.
Delta Opioid Receptor 358-372 Blocking Peptide